Four of our panelists discuss their favorite investments in the final installment of our 2025 stock-picking confab.

The Hong Kong stock market has moved lower in two straight sessions, shedding more than 400 points or 2 percent along the way. The ...

Driven by Biopharmaceutical Innovations and Gene Therapies, the market Booms Amidst Growing Incidence of Hemophilia and Von Willebrand Disease ...

The Hong Kong stock market on Wednesday snapped the six-day winning streak in which it had surged more than 1,230 points or 6 ...

WuXi Biologics is expected to deliver faster sales growth and higher margins this year. Click here to find out why I upgraded ...

In another Chinese newco out-licensing deal, Innocare Pharma Ltd. and Keymed Biosciences Co. Ltd. out-licensed their co-developed CD20×CD3 bispecific antibody (ICP-B02/CM355) to startup Prolium ...

China’s health regulator gave conditional approval to Platinum Life Excellence Biotech Co. Ltd.’s amimestrocel injection (hUC-MSC PLEB-001, Ruibosheng) as the nation’s first human umbilical ...

A Chinese pharmaceutical company expects to hire up to 500 employees for the first phase of its new campus in northern ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...

Find insight on Tencent, TikTok, Reach and more in the latest Market Talks covering Technology, Media and Telecom.

Shares of WuXi group companies jumped Monday after U.S. President-elect Trump promised to save TikTok and held a call with his counterpart in China, sparking tentative hopes that some areas of ...